
Continuous glucose monitoring (CGM) is a potential health-technology theme to research, but the discussion names no companies, tickers, price targets, or investment timeframe. Don’t treat the health claims as evidence of investment potential; assess individual companies and risks before investing.

By @thediaryofaceo
64% of our viewers don't realise they don't subscribe, please double check, thank you!!